BDCA2 (Cyno) Binding Molecules Screening Assay, CHOK1/BDCA2-based (CAT#: ITS-1122-LX101)

CHOK1/BDCA2 (Cyno)

Human

Creative Biolabs has developed several immune checkpoint stable cell Lines expressing the most popular immune checkpoints to accelerate clients' immunotherapy discovery and clinical translation. cyno BDCA2 Stable Cell Line, CHO-K1 is constructed to constitutively expressing cyno BDCA2. Which can be used in binding assays and functional assay.

CHOK1

Cancer

Oncology

In Vitro Cell Binding Assay

Screening and profiling for BDCA2 (Cyno) binding molecules (such as anti-BDCA2 antibody, ADC) in a cellular context.

Drug candidates screening and profiling assay as a most important analysis for drug discovery. Creative Biolabs provides In Vitro BDCA2 (Cyno) Binding Molecules Screening Assay to screen BDCA2 (Cyno) binding molecules (such as anti-BDCA2 antibody, ADC) by cell-based binding FACS analysis. The assay will be customized according to the client's specific requirements. Please contact our scientists to discuss more details.

Cell-based Binding Assay; Drug Screening and Profiling assay

Cell Binding Assay

Screening and profiling BDCA2 (Cyno) binding molecules (such as anti-BDCA2 antibody, ADC) by cell-based binding FACS analysis.

Creative have developed the stable cell line CHO-K1/BDCA2 (Cyno), which is designed for screening and profiling BDCA2 (Cyno) binding molecules (such as anti-BDCA2 antibody, ADC) by cell-based binding FACS analysis.